PMV Pharmaceuticals, Inc.
PMVP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $40,876 | $37,706 | $108,297 | $172,467 |
| Short-Term Investments | $128,578 | $165,351 | $132,757 | $124,696 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6,204 | $4,352 | $5,952 | $4,123 |
| Total Curr. Assets | $175,658 | $207,409 | $247,006 | $301,286 |
| Property Plant & Equip (Net) | $1,552 | $19,048 | $20,494 | $13,150 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $13,843 | $25,505 | $2,495 | $16,911 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $235 | $190 | $313 | $221 |
| Total NC Assets | $15,630 | $44,743 | $23,302 | $30,282 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $191,288 | $252,152 | $270,308 | $331,568 |
| Liabilities | – | – | – | – |
| Payables | $6,579 | $3,237 | $2,996 | $3,189 |
| Short-Term Debt | $352 | $852 | $528 | $403 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7,439 | $9,940 | $7,308 | $8,627 |
| Total Curr. Liab. | $14,370 | $14,029 | $10,832 | $12,219 |
| LT Debt | $838 | $12,434 | $13,448 | $10,790 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $838 | $12,434 | $13,448 | $10,790 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $838 | $13,286 | $13,976 | $11,193 |
| Total Liabilities | $15,208 | $26,463 | $24,280 | $23,009 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$368,712 | -$310,003 | -$241,043 | -$167,726 |
| AOCI | $139 | $224 | -$445 | -$78 |
| Other Equity | $544,653 | $535,468 | $487,516 | $476,363 |
| Total Equity | $176,080 | $225,689 | $246,028 | $308,559 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $191,288 | $252,152 | $270,308 | $331,568 |
| Net Debt | -$39,686 | -$24,420 | -$94,321 | -$161,274 |